A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus Infection

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 13, 2015

Primary Completion Date

August 22, 2016

Study Completion Date

October 31, 2016

Conditions

Chronic Hepatitis CCirrhosisHepatitis C Virus

Interventions

DRUG

ombitasvir/paritaprevir/ritonavir and dasabuvir

Tablet; ombitasvir coformulated with paritaprevir and ritonavir, dasabuvir tablet

DRUG

Ribavirin

Tablet